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Abstract  
Chronic fetal hypoxia and infection are examples of adverse conditions during complicated 
pregnancy, which impact cardiac myogenesis and increase the lifetime risk of heart disease. 
However, the effects that chronic hypoxic or inflammatory environments exert on cardiac 
pacemaker cells are poorly understood. Here, we review the current evidence and novel avenues 
of bench-to-bed research in this field of perinatal cardiogenesis as well as its translational 
significance for early detection of future risk for cardiovascular disease.  
 
 
 
  
3 
Introduction 
A suboptimal prenatal environment, such as fetal exposure to diminished nutrient or oxygen 
supply, impacts myocardial development predisposing to cardiometabolic disorders in later 
life.[1,2] There is however no direct data during development so far on the timing of the 
emergence of the cardiac pacemaker cell synchronization (CPS) nor on the effects of adverse 
intrauterine conditions on cardiac pacemaker cell development and alterations of CPS; the basis 
for an altered fetal heartbeat. Interestingly, some of the recent insight into cardiac pacemaker cell 
development comes from bioengineering.  This has focused on the creation of biological 
pacemakers [3,4], the biology of the human pluripotent stem cells differentiating into adult 
cardiomyocytes [5], as well as transcriptomics associated with cardiac mature pacemaker cell 
function at single-cell resolution.[6] 
 
The analysis of fetal heart rate variability (HRV) has been the mainstay of noninvasive fetal health 
monitoring for decades, yet its utility to identify endangered fetuses has remained limited.[7,8] In 
this review, we will discuss how the CPS provides the subcellular, cellular and multicellular 
substrate for the emergence of an intrinsic fetal HRV (iHRV). We hope that expanding research 
into the iHRV as a proxy to fetal cardiac health will not only help in the diagnosis of fetuses at risk 
in adverse pregnancy, but that it will also inspire future studies into this aspect of cardiac cellular 
development and its significance for the early detection of cardiac diseases in later life.[9,10]  
 
The heartbeat is generated by the sinoatrial node, a small region in the right atrium of the heart,  
comprised of approximately 10,000 cells that interact with each other to set the normal cardiac 
rhythm. The fluctuations in heart rate result from a combination of its own intrinsic variability and 
the modulation of the pacemaker activity by several neural and endocrine control mechanisms 
(Fig. 1).[11] Remarkably, the intrinsic fluctuations of the heartbeat are seen not only in the isolated 
node, devoid of all neural and hormonal inputs but also at the single pacemaker cell level, isolated 
from the node.[12] The electrical activity in such a single cell is generated by ions flowing through 
discrete channels within the cell membrane.  
 
Based on experimental data, in an in silico pacemaker model consisting of roughly 6000 channels, 
the intrinsic dynamics of the irregular beating seen experimentally in single nodal cells was shown 
to be due to the (pseudo)random opening and closing of single channels.[13] 
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In addition to synchronization between single-channel activity, pacemaker cells rely on an 
interstitial tissue architecture for their isolation from the rest of the myocardium and a reservoir of 
brown adipose tissue for ready access to energy substrates.[14–16]  
 
Together, these three components (Fig. 1), made up of ion channels, isolated tissue and 
the energy reservoir form a dynamic system responsible for the generation of the 
heartbeat and its vulnerability to developmental challenges, such as exposure to hypoxia 
or infection, which in turn may determine future susceptibility to dysfunction in later life. 
 
1) How is cardiac pacemaker synchronization (CPS) achieved? 
There is no universally accepted mechanism explaining CPS. However, several important 
contributing components have been identified. 
 
Each channel in a pacemaker cell has one or more gates, all of which must be open to allow 
current to flow through the channel. Since these gates are thought to open and close in a random 
manner, each gate can be modeled by a Markov process, assigning a pseudorandom number to 
each gate every time that it changes state from open to closed or vice versa. This number, in 
conjunction with the classical voltage‐dependent Hodgkin Huxley‐like rate constants that control 
the speed with which a gate will open or close, then determines when that gate will next change 
state. In the study by Guevara and Lewis [13], the model’s behavior was consistent with the 
hypothesis that the irregular beating seen experimentally in single nodal cells is due to the 
(pseudo)random opening and closing of single channels. However, since the pseudorandom 
number generator used in the simulations is deterministic, one cannot state that the activity in the 
model is random (or stochastic).  
 
If one or more electric shocks are delivered directly to the heart near the intrinsic pacemaker, the 
heart rhythm is modified transiently but re-establishes itself with the same frequency as before 
within a few seconds.[17] Such behavior represents a memory of the pattern of the intrinsic CPS, 
an imprint of the physiological relationship between the pacemaker cells and their dynamic 
properties, at the channel, cellular and multicellular levels. 
In addition to the complex temporal dynamics of CPS based on the channel physiology and self-
organization, there is an emerging role for compartmentalized (i.e., associated with distinct, 
spatially-confined microdomains) organization of pacemaker signaling complexes in the sinoatrial 
node pacemaker cells.[6] Upon structural remodeling of the sinoatrial node, disruption in 
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subcellular targeting of pacemaker proteins and associated signaling molecules may affect their 
biophysical properties, neurohormonal regulation as well as protein–protein interactions within the 
pacemaker signaling complex. This will disturb rhythmic generation of action potentials, thereby 
contributing to the pathophysiology of the sinus node function. Evidence for these relationships is 
clear, derived from patients and animal models with genetic defects of scaffolding proteins, which 
are closely associated with sinus node disease. For instance, via indirect changes of key 
components in the coupled-clock systems in terms of protein expression, function and membrane 
localization. This extends beyond the classical concept of electrical remodeling, according to 
which dysfunction can be explained by straightforward increases or decreases in protein 
expression alone, and adds a new dimension to cardiovascular disease. It thus introduces a novel 
framework for therapeutic approaches for the treatment of pacemaker dysfunction, targeted at 
preventing the degradation of cardiac cytoarchitecture or abnormalities in the 
compartmentalization of cardiac pacemaker microdomains, incurred as a result of the intrauterine 
insults.[18]  
 
The single-cell resolution in situ study of cardiac conduction system has recently yielded an 
unprecedented and detailed transcriptional biomarker landscape of the cardiac pacemaker cells 
that includes ion channels (Hcn4, Hcn1, hyperpolarization-activated cyclic nucleotide-gated 
channels 4 and 1), transcription factors (Isl1, Tbx3, Tbx18, Shox2), gap junction gene Gjc1, Igfbp5 
(insulin-like growth factor–binding protein 5), Smoc2 (SPARC-related modular calcium-binding 
protein), Ntm (Neurotrimin), Cpne5 (Copine 5) and Rgs6 (regulator of G-protein signaling type 
6).[6,19] These represent targets for future studies of CPS development in utero in healthy and 
complicated pregnancy (Fig. 1). 
 
The automaticity of action potentials within the sinoatrial node’s pacemaker cells is driven by a 
dynamic, bidirectionally coupled interaction of two clock systems.  These are represented by the 
spontaneous rhythmic local Ca2+ releases generated by a Ca2+ clock and the activity of the 
electrogenic surface membrane molecules, especially the ion channels (the M clock). The 
coupling between the intracellular Ca2+ and the fluctuations of the surface membrane potential is 
mediated by the Ca2+–cAMP–protein kinase A (PKA) signaling. Consequently, beta-adrenergic 
receptor stimulation can restore or further enhance this coupling and the CPS, as it increases the 
cAMP concentrations.[10] The study highlights how dependent CPS is on energy availability and 
complements in this sense the work by Gu and colleagues[20], discussed further below.  
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Future developmental studies of the expression profiles of these biomarkers should yield insights 
into how physiological and pathophysiological stimuli during gestation impact the maturation and 
synchronization of the cardiac pacemaker cells. 
 
2) How is CPS impacted by developmental hypoxia and infection? 
CPS memory goes beyond re-establishing its intrinsic rhythm. Cardiac disease can also impair 
CPS leaving its “memory imprint” on it.[9] That is, impaired intrinsic properties of pacemaker cells 
become manifest in an altered heart rate and HRV in the context of heart disease.[9] Ischemia 
slows pacemaker activity in rabbit sinoatrial node pacemaker cells because two inward currents, 
ICa,T and a presumed INCX, are diminished.[21]  
 
Infection, in particular, gram-negative bacterial infection impacts CPS and hence HRV via direct 
effects on pacemaker channels resulting in ionic current remodeling.[22,23] This was studied in 
the human hyperpolarization-activated cyclic nucleotide-gated channel 2 (hHCN2), which is stably 
expressed in HEK293 and cardiac pacemaker cells, exposed to lipopolysaccharides (LPS). The 
‘funny’ current (If) of pacemaker cells is the main membrane mechanism generating the diastolic 
depolarization; the phase of the action potential responsible for cardiac spontaneous activity. If is 
also responsible for the modulation of the heart rate by the autonomic nervous system (ANS).[24] 
LPS released from Gram‐negative bacteria during severe sepsis reduces both native If and 
HCN2‐ or HCN4‐mediated currents and shifts their activation to more negative potentials.[25] The 
LPS effect is not mediated by any of the intracellular modulatory pathways affecting HCN 
channels, but is instead due to a direct interaction with the channel.[22] Klöckner et al. have shown 
that alterations of the HCN current require the integrity of the LPS molecule, since neither the pro‐
inflammatory lipid A alone nor the O‐chain polysaccharidic region alone were effective. LPS 
release during sepsis can modify the If properties by shifting them out of their physiological range, 
which may impair normal rate control and decrease the cardiac safety factor, making the system 
more prone to life‐threatening perturbations (Fig. 1).[25] 
 
In a recent study, the vulnerability of sinus node cells to lipotoxicity has been highlighted.[26] 
Future studies should investigate how this vulnerability relates to fetal exposures to malnutrition, 
maternal obesity, chronic hypoxia and IUGR. 
 
Energy availability plays a role in CPS via modulation of the mitochondrial dynamics.[20] While 
the data in induced cardiac pacemaker cells should be considered with caution, as it compares 
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to native cardiac pacemaker cells, this approach represents one of the rare opportunities to study 
this rare subpopulation of human cardiac myocytes with rhythm generating properties. The 
isolated, native sinoatrial node cells exhibited a remarkable resilience to prolonged hypoxia 
followed by reoxygenation [27–29], a condition that would irreversibly damage chamber 
cardiomyocytes. This is due to a significantly lower global metabolic demand in the cardiac 
pacemaker cells compared to cardiomyocytes. It remains to be investigated whether and from 
what time point in gestation the fetal cardiac pacemaker cells exhibit similar ischemia tolerance 
and what consequences such ischemic events have on programming CPS properties and 
susceptibility to future insults, e.g., with increased risk for arrhythmia development. 
 
Overall, ischemia and infection modulate CPS via altering the intrinsic properties of the electrical 
activity of pacemaker cells. This may lead to changes in HRV and arrhythmia.[30] Three major 
components with varying degrees of vulnerabilities to adverse intrauterine conditions emerge, 
namely HCN2/HCN4 channels, brown adipose tissue and the intercellular matrix (Fig. 1). It is 
likely that interference by LPS, ischemia, hypoxia or fibrosis with any of these constituents of the 
cardiac pacemaker cell environment, would yield delays in CPS maturation and function. 
 
3) CPS and fetal development? 
What are the most relevant currents to focus on that contribute to CPS and iHRV?[26,31] The 
literature suggests that these are the If, mediated in particular via HCN4. How do these behave 
during fetal and early postnatal development?  
 
In the rabbit, the sodium current (I(Na)) contributes to the sinoatrial node automaticity in the 
newborn but not in the adult period, when heart rate is slower. In contrast, heart rate is high and 
the I(Na) is functional in the adult mouse sinoatrial node. [32] Canine sinoatrial node cells have 
TTX-sensitive I(Na), which decreases with postnatal age. The current does not contribute to 
normal automaticity in isolated adult cells but can be recruited to sustain excitability if nodal cells 
are hyperpolarized. This is particularly relevant in the fetal and newborn periods, when the I(Na) 
is large and the autonomic balance favors vagal tone. 
 
The pacemaker current, If, is expressed in ventricular myocytes from neonatal rats and 
progressively disappears with advancing age. When present, it shows electrophysiological 
properties similar to If re-expressed in hypertrophied adult rat ventricular myocytes. Thus, it is 
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likely that the occurrence of If in ventricular myocytes of hypertrophied and failing hearts is due to 
the re-expression of a fetal gene.[33] 
 
In the heart, both during development and in adulthood, the kinetic properties and expression 
levels of If match the need of the cells to perform pacemaker activity. While at immature stages 
of embryonic development all cardiomyocytes are autorhythmic and express a robust If current 
activated within the physiological range of voltages, shortly after birth the pacemaker activity and 
If expression become restricted to cells of the conduction system only, while in the working 
myocardium the current is downregulated and its activation is shifted to more negative, non‐
physiological voltages.[24] 
 
The characteristics of native If are the results of a complex interplay between different factors. 
The kinetic properties and expression levels of the f‐channels, encoded by the HCN genes 
(HCN1–4), are finely regulated by auxiliary proteins (caveolin‐3, MiRP‐1, KCR‐1, SAP97, TRP8) 
and lipids (phosphatidylinositol 4,5‐bisphosphate) as well as by post‐translational modifications, 
such as phosphorylation and glycosylation. Any alteration of these regulatory pathways may 
modify the contribution of If to the action potential, leading to an arrhythmogenic phenotype.[24] 
 
It is not clear when and how gradually during gestation the CPS develops,  so that we can speak 
of a “healthy” intrinsic pacemaker rhythm.  These unknowns, as well as the genetic program of 
pacemaker cell development, are under investigation.[3,34,35] Our recent data suggest that fetal 
intrinsic beat-to-beat HRV is present in the healthy fetus near-term and shows a memory of 
previous exposure to chronic hypoxia.[36] The two-clock coupling mechanism discussed in 
section 1 [10] may provide at least a partial explanation for this memory to chronic hypoxic 
conditions which, in addition to lowering energy availability, is known to program sympathetic 
hyperactivity in the offspring.[36–38] 
4) What is iHRV? 
From studies of healthy adult subjects during exercise and studies of heart-transplant patients, 
the field is aware that intrinsic components of cardiac rhythm can contribute substantially to 
HRV.[11,39,40] The iHRV is thought to result from a three-scale level system of synchronization 
occurring at the ion channel, cell and multi-cell layers of organization.[41] At each of these levels, 
various physiological and pathophysiological stimuli shape, modulate and program the 
synchronization properties and the development CPS in ways we are only just beginning to 
unravel. These intrinsic fluctuations at multiple time scales combined with a modulatory input from 
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the ANS explain, at least in part, the fractal and complexity properties of iHRV, 
respectively.[11,23,40] With regard to modulation by the ANS, the focus so far has been on 
sympathetic beta-adrenergic signaling. Future work should also explore the modulation by vagal 
components. 
 
We have recently discovered that iHRV originates in fetal life and that chronic fetal hypoxia 
significantly alters it.[36] Interestingly, iHRV and its memory of chronic fetal hypoxia are 
characterized by nonlinear properties reflecting its recurrent state and chaotic behavior;  
properties inherent of fractal dynamics.[42] The significant relationship between nonlinear 
measures of fetal iHRV and left ventricular end-diastolic pressure (LVEDP), which is elevated in 
fetuses from hypoxic pregnancy, suggests that such iHRV indices could reflect fetal myocardial 
dysfunction, particularly during cardiac diastole. Therefore, alterations in fetal iHRV may prove 
clinically useful as a biomarker of impaired cardiac reserve and fetal myocardial decompensation 
during antepartum or intrapartum monitoring of the fetal heart in a high-risk pregnancy or 
complicated labor. 
 
What are the mechanisms contributing to fetal iHRV in late gestation in a normal pregnancy? The 
above review of the mechanisms underlying the CPS and influences on its activity suggests a 
number of factors capable of impacting the ion channel activity directly, such as LPS or hypoxia, 
via energy availability or via the alterations in the compartmentalization architecture of the 
sinoatrial node pacemaker cells. We describe in Section 1 twelve genes involved in the 
programmed differentiation of the cardiac pacemaker cells throughout embryonic development. 
The disruption of this complex spatiotemporal genetic program is likely to impact the CPS and 
hence leave a pathophysiological imprint on the susceptibility of the cardiac pacemaker cells to 
future insults, in particular cardiac arrhythmia or arrest. The study of the two-clock coupling-based 
generation of CPS underscores the intricate interplay between the cardiac pacemaker cells, 
neural autonomic input and energy availability as another layer of the putative transfer 
mechanisms of in utero hypoxia upon iHRV.[10] This likely dependence upon sympathetic 
influences links fetal adaptation to chronic stressors with the autochthonic responses within the 
cardiac pacemaker cell network, emerging from the adaptive processes within the excitatory cells 
themselves in response to chronic hypoxia. Therefore, there are several putative transfer 
mechanisms by which in utero chronic hypoxia may imprint upon iHRV. A systematic exploration 
of such candidate pathways would be a rich future avenue of research (summarized in Fig. 1). 
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5) Can the impact of fetal hypoxia or infection on CPS be captured by HRV monitoring?  
In the above sections, we discuss the contributions to CPS, iHRV and HRV of the complex, multi-
layered activity of the cardiac pacemaker cells. This opens a multitude of questions regarding the 
clinical application, which we list below in the hope that they will inspire future investigations:  
a) Are there suitable HRV properties likely to capture iHRV in vivo? In [36] we report such 
putative HRV measures representing recurrent states, chaotic and fractal dynamics. We 
invite the interested reader to explore this study and test the identified measurable 
outcomes in their own investigations;  
b) Could we distinguish between the effect of chronic fetal hypoxia versus inflammation on 
CPS from HRV analysis? Our findings ex vivo indicate an impact of chronic hypoxia on 
CPS and iHRV and studies in vivo identified HRV signatures capable of tracking fetal 
systemic and gut- and brain-specific inflammatory responses over a period of days [43–
45]. However, it is yet not clear to what extent the HRV measures identified in these 
studies reflect contributions from iHRV. The mechanisms discussed in Section 2 support 
this possibility. To date, no data exist on the specificity of HRV outcomes to selective 
challenges, such as cardiac inflammation. This remains the subject of future studies; 
c) What is the relationship between CPS and myocardial development? In a recent study, 
we found a significant correlation between fetal iHRV and two measures of fetal cardiac 
diastolic dysfunction, namely LVEDP and the minimum rate of change of ventricular 
pressure (dP/dt) in fetuses from pregnancy affected by chronic hypoxia.[36] Could this 
reflect a dual pathological impact of hypoxia on both cardiomyocyte and pacemaker cell 
development? Alternatively, could these relationships reflect a functional physiological 
adaptive response relationship between these cell populations? These questions remain 
open to debate; 
d) The HRV code has been proposed as an overarching concept incorporating the various 
multi-scale contributions of inter-organ communication reflected in HRV.[8,46,47] We 
suggest that an understanding of the impact on CPS of chronic fetal hypoxia or infection 
during pregnancy should be sought within the integrative framework of the HRV code; 
e) Could we use mathematical modeling to derive predictions for HRV properties, likely to 
work as iHRV biomarkers in the human clinical setting? Mathematical models exist for 
CPS and fetal cardiovascular responses to labor, for example.[48,49] Such models could 
be combined and explored in silico to derive numerical predictions of HRV properties 
specific to fetal iHRV and their quantitative contribution to fetal cardiac function in vivo. 
 
11 
6) Conclusions and outlook 
The three major components of the cardiac pacemaker system, comprised of the cellular ion 
channels, isolated tissue and the energy reservoir, form a dynamic network responsible for the 
generation of iHRV (Fig. 1). Future studies should determine the spatiotemporal vulnerability of 
this system, i.e., time periods during embryonic and fetal development that are particularly 
sensitive and susceptible to adverse intrauterine insults, such as chronic hypoxia or infection. This 
developmental vulnerability, in turn, may determine future susceptibility to cardiac dysfunction or 
limited tolerance in later life. 
 
Specifically, the following molecular candidate targets could provide interesting studies of CPS 
development in utero and postnatally: ion channels (Hcn4, Hcn1), transcription factors (Isl1, Tbx3, 
Tbx18, Shox2), gap junction gene Gjc1, Igfbp5, Smoc2, Ntm, Cpne5 and Rgs6. Functional studies 
in pacemaker cells should explore the developmental profile of CPS dynamics in vitro or using 
the Langendorff preparation ex vivo with attention to the vulnerability of the CPS to noxious stimuli 
such as ischemia, hypoxia or inflammation. To gauge the impact of energy availability during 
intrauterine development on CPS maturation, the effects of alterations in nutrition on CPS 
development should be investigated. Such studies could involve maternal malnutrition or maternal 
obesity during pregnancy with or without chronic hypoxia and/or infection to assess partial and 
combined effects. Such studies would also permit the spatial and qualitative characterization of 
changes to the isolating tissue, such as fibrosis, and the micro-domain organization within the 
cardiac pacemaker cells. 
 
  
12 
Acknowledgements 
MGF has been funded by the Canadian Institutes of Health Research (CIHR). DAG has been 
funded by the British Heart Foundation (BHF).  
13 
References 
1.  McMillen, I.C.; Robinson, J.S. Developmental origins of the metabolic syndrome: prediction, 
plasticity, and programming. Physiol. Rev. 2005, 85, 571–633. 
2.  Giussani, D.A.; Davidge, S.T. Developmental programming of cardiovascular disease by 
prenatal hypoxia. J. Dev. Orig. Health Dis. 2013, 4, 328–337. 
3.  Vedantham, V. New Approaches to Biological Pacemakers: Links to Sinoatrial Node 
Development. Trends Mol. Med. 2015, 21, 749–761. 
4.  Protze, S.I.; Liu, J.; Nussinovitch, U.; Ohana, L.; Backx, P.H.; Gepstein, L.; Keller, G.M. 
Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a 
biological pacemaker. Nat. Biotechnol. 2017, 35, 56–68. 
5.  van den Heuvel, N.H.L.; van Veen, T.A.B.; Lim, B.; Jonsson, M.K.B. Lessons from the 
heart: mirroring electrophysiological characteristics during cardiac development to in vitro 
differentiation of stem cell derived cardiomyocytes. J. Mol. Cell. Cardiol. 2014, 67, 12–25. 
6.  Goodyer, W.R.; Beyersdorf, B.M.; Paik, D.T.; Tian, L.; Li, G.; Buikema, J.W.; Chirikian, O.; 
Choi, S.; Venkatraman, S.; Adams, E.L.; et al. Transcriptomic Profiling of the Developing 
Cardiac Conduction System at Single-Cell Resolution. Circ. Res. 2019, 125, 379–397. 
7.  Georgieva, A.; Abry, P.; Chudáček, V.; Djurić, P.M.; Frasch, M.G.; Kok, R.; Lear, C.A.; 
Lemmens, S.N.; Nunes, I.; Papageorghiou, A.T.; et al. Computer-based intrapartum fetal 
monitoring and beyond: a review of the 2nd Workshop on Signal Processing and Monitoring 
in Labor (Oct 2017, Oxford UK). Acta Obstet. Gynecol. Scand. 2019. 
8.  Frasch, M.G. Saving the brain one heartbeat at a time. J. Physiol. 2018, 2018/04/01. 
9.  Yaniv, Y.; Lyashkov, A.E.; Lakatta, E.G. Impaired signaling intrinsic to sinoatrial node 
pacemaker cells affects heart rate variability during cardiac disease. J Clin Trials 2014, 4. 
10.  Tsutsui, K.; Monfredi, O.J.; Sirenko-Tagirova, S.G.; Maltseva, L.A.; Bychkov, R.; Kim, M.S.; 
Ziman, B.D.; Tarasov, K.V.; Tarasova, Y.S.; Zhang, J.; et al. A coupled-clock system drives 
the automaticity of human sinoatrial nodal pacemaker cells. Sci. Signal. 2018, 11. 
11.  Yaniv, Y.; Lyashkov, A.E.; Lakatta, E.G. The fractal-like complexity of heart rate variability 
beyond neurotransmitters and autonomic receptors: signaling intrinsic to sinoatrial node 
pacemaker cells. Cardiovasc Pharm Open Access 2013, 2. 
12.  Wilders, R.; Jongsma, H.J. Beating irregularity of single pacemaker cells isolated from the 
rabbit sinoatrial node. Biophys. J. 1993, 65, 2601–2613. 
13.  Guevara, M.R.; Lewis, T.J. A minimal single-channel model for the regularity of beating in 
the sinoatrial node. Chaos 1995, 5, 174–183. 
14.  Bressan, M.; Henley, T.; Louie, J.D.; Liu, G.; Christodoulou, D.; Bai, X.; Taylor, J.; Seidman, 
C.E.; Seidman, J.G.; Mikawa, T. Dynamic Cellular Integration Drives Functional Assembly 
of the Heart’s Pacemaker Complex. Cell Rep. 2018, 23, 2283–2291. 
15.  Unudurthi, S.D.; Wolf, R.M.; Hund, T.J. Role of sinoatrial node architecture in maintaining a 
balanced source-sink relationship and synchronous cardiac pacemaking. Front. Physiol. 
2014, 5, 446. 
16.  Fahrenbach, J.P.; Mejia-Alvarez, R.; Banach, K. The relevance of non-excitable cells for 
cardiac pacemaker function. J. Physiol. 2007, 585, 565–578. 
17.  Glass, L. Synchronization and rhythmic processes in physiology. Nature 2001, 410, 277–
284. 
18.  Lang, D.; Glukhov, A.V. Functional Microdomains in Heart’s Pacemaker: A Step Beyond 
Classical Electrophysiology and Remodeling. Frontiers in Physiology 2018, 9. 
19.  Hoogaars, W.M.H.; Engel, A.; Brons, J.F.; Verkerk, A.O.; de Lange, F.J.; Wong, L.Y.E.; 
Bakker, M.L.; Clout, D.E.; Wakker, V.; Barnett, P.; et al. Tbx3 controls the sinoatrial node 
gene program and imposes pacemaker function on the atria. Genes Dev. 2007, 21, 1098–
1112. 
14 
20.  Gu, J.-M.; Grijalva, S.I.; Fernandez, N.; Kim, E.; Foster, D.B.; Cho, H.C. Induced cardiac 
pacemaker cells survive metabolic stress owing to their low metabolic demand. Exp. Mol. 
Med. 2019, 51, 105. 
21.  Du, Y.-M.; Nathan, R.D. Ionic basis of ischemia-induced bradycardia in the rabbit sinoatrial 
node. J. Mol. Cell. Cardiol. 2007, 42, 315–325. 
22.  Klockner, U.; Rueckschloss, U.; Grossmann, C.; Matzat, S.; Schumann, K.; Ebelt, H.; 
Muller-Werdan, U.; Loppnow, H.; Werdan, K.; Gekle, M. Inhibition of cardiac pacemaker 
channel hHCN2 depends on intercalation of lipopolysaccharide into channel-containing 
membrane microdomains. J. Physiol. 2014, 592, 1199–1211. 
23.  Papaioannou, V.E.; Verkerk, A.O.; Amin, A.S.; de Bakker, J.M. Intracardiac origin of heart 
rate variability, pacemaker funny current and their possible association with critical illness. 
Curr. Cardiol. Rev. 2013, 9, 82–96. 
24.  DiFrancesco, D. The role of the funny current in pacemaker activity. Circ. Res. 2010, 106, 
434–446. 
25.  Barbuti, A.; DiFrancesco, D. The “funny” side of sepsis. J. Physiol. 2014, 592, 1171. 
26.  Linscheid, N.; Logantha, S.J.R.J.; Poulsen, P.C.; Zhang, S.; Schrölkamp, M.; Egerod, K.L.; 
Thompson, J.J.; Kitmitto, A.; Galli, G.; Humphries, M.J.; et al. Quantitative proteomics and 
single-nucleus transcriptomics of the sinus node elucidates the foundation of cardiac 
pacemaking. Nat. Commun. 2019, 10, 2889. 
27.  Kohlhardt, M.; Mnich, Z.; Maier, G. Alterations of the excitation process of the sinoatrial 
pacemaker cell in the presence of anoxia and metabolic inhibitors. J. Mol. Cell. Cardiol. 
1977, 9, 477–488. 
28.  Senges, J.; Mizutani, T.; Pelzer, D.; Brachmann, J.; Sonnhof, U.; Kübler, W. Effect of 
hypoxia on the sinoatrial node, atrium, and atrioventricular node in the rabbit heart. Circ. 
Res. 1979, 44, 856–863. 
29.  Nishi, K.; Yoshikawa, Y.; Sugahara, K.; Morioka, T. Changes in electrical activity and 
ultrastructure of sinoatrial nodal cells of the rabbit’s heart exposed to hypoxic solution. Circ. 
Res. 1980, 46, 201–213. 
30.  Yaniv, Y.; Tsutsui, K.; Lakatta, E.G. Potential effects of intrinsic heart pacemaker cell 
mechanisms on dysrhythmic cardiac action potential firing. Front. Physiol. 2015, 6, 47. 
31.  Lakatta, E.G.; DiFrancesco, D. What keeps us ticking: a funny current, a calcium clock, or 
both? J. Mol. Cell. Cardiol. 2009, 47, 157–170. 
32.  Protas, L.; Oren, R.V.; Clancy, C.E.; Robinson, R.B. Age-dependent changes in Na current 
magnitude and TTX-sensitivity in the canine sinoatrial node. J. Mol. Cell. Cardiol. 2010, 48, 
172–180. 
33.  Cerbai, E.; Pino, R.; Sartiani, L.; Mugelli, A. Influence of postnatal-development on I(f) 
occurrence and properties in neonatal rat ventricular myocytes. Cardiovasc. Res. 1999, 42, 
416–423. 
34.  Hu, W.; Xin, Y.; Zhao, Y.; Hu, J. Shox2: The Role in Differentiation and Development of 
Cardiac Conduction System. Tohoku J. Exp. Med. 2018, 244, 177–186. 
35.  Vedantham, V.; Galang, G.; Evangelista, M.; Deo, R.C.; Srivastava, D. RNA sequencing of 
mouse sinoatrial node reveals an upstream regulatory role for Islet-1 in cardiac pacemaker 
cells. Circ. Res. 2015, 116, 797–803. 
36.  Frasch, M.G.; Herry, C.L.; Niu, Y.; Giussani, D.A. First evidence that intrinsic fetal heart rate 
variability exists and is affected by hypoxic pregnancy. J. Physiol. 2019. 
37.  Giussani, D.A.; Camm, E.J.; Niu, Y.; Richter, H.G.; Blanco, C.E.; Gottschalk, R.; Blake, 
E.Z.; Horder, K.A.; Thakor, A.S.; Hansell, J.A.; et al. Developmental programming of 
cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One 2012, 7, 
e31017. 
38.  Rouwet, E.V.; Tintu, A.N.; Schellings, M.W.M.; van Bilsen, M.; Lutgens, E.; Hofstra, L.; 
Slaaf, D.W.; Ramsay, G.; Le Noble, F.A.C. Hypoxia induces aortic hypertrophic growth, left 
15 
ventricular dysfunction, and sympathetic hyperinnervation of peripheral arteries in the chick 
embryo. Circulation 2002, 105, 2791–2796. 
39.  Bernardi, L.; Salvucci, F.; Suardi, R.; Solda, P.L.; Calciati, A.; Perlini, S.; Falcone, C.; 
Ricciardi, L. Evidence for an intrinsic mechanism regulating heart rate variability in the 
transplanted and the intact heart during submaximal dynamic exercise? Cardiovasc. Res. 
1990, 24, 969–981. 
40.  Yaniv, Y.; Ahmet, I.; Liu, J.; Lyashkov, A.E.; Guiriba, T.R.; Okamoto, Y.; Ziman, B.D.; 
Lakatta, E.G. Synchronization of sinoatrial node pacemaker cell clocks and its autonomic 
modulation impart complexity to heart beating intervals. Heart Rhythm 2014, 11, 1210–
1219. 
41.  Binah, O.; Weissman, A.; Itskovitz-Eldor, J.; Rosen, M.R. Integrating beat rate variability: 
from single cells to hearts. Heart Rhythm 2013, 10, 928–932. 
42.  Webber, C.L., Jr Recurrence quantification of fractal structures. Front. Physiol. 2012, 3, 
382. 
43.  Durosier, L.D.; Herry, C.L.; Cortes, M.; Cao, M.; Burns, P.; Desrochers, A.; Fecteau, G.; 
Seely, A.J.E.; Frasch, M.G. Does heart rate variability reflect the systemic inflammatory 
response in a fetal sheep model of lipopolysaccharide-induced sepsis? Physiol. Meas. 
2015, 36, 2089–2102. 
44.  Herry, C.L.; Cortes, M.; Wu, H.-T.; Durosier, L.D.; Cao, M.; Burns, P.; Desrochers, A.; 
Fecteau, G.; Seely, A.J.E.; Frasch, M.G. Temporal Patterns in Sheep Fetal Heart Rate 
Variability Correlate to Systemic Cytokine Inflammatory Response: A Methodological 
Exploration of Monitoring Potential Using Complex Signals Bioinformatics. PLoS One 2016, 
11, e0153515. 
45.  Liu, H.L.; Garzoni, L.; Herry, C.; Durosier, L.D.; Cao, M.; Burns, P.; Fecteau, G.; 
Desrochers, A.; Patey, N.; Seely, A.J.E.; et al. Can Monitoring Fetal Intestinal Inflammation 
Using Heart Rate Variability Analysis Signal Incipient Necrotizing Enterocolitis of the 
Neonate? Pediatr. Crit. Care Med. 2016, 17, e165–76. 
46.  Herry, C.L.; Burns, P.; Desrochers, A.; Fecteau, G.; Durosier, L.D.; Cao, M.; Seely, A.J.E.; 
Frasch, M.G. Vagal contributions to fetal heart rate variability: an omics approach. Physiol. 
Meas. 2019, 40, 065004. 
47.  Frasch, M.G. Heart rate variability code: Does it exist and can we hack it? arXiv [q-bio.TO] 
2020. 
48.  Zhang, H.; Holden, A.V.; Kodama, I.; Honjo, H.; Lei, M.; Varghese, T.; Boyett, M.R. 
Mathematical models of action potentials in the periphery and center of the rabbit sinoatrial 
node. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H397–421. 
49.  Wang, Q.; Gold, N.; Frasch, M.G.; Huang, H.; Thiriet, M.; Wang, X. Mathematical Model of 
Cardiovascular and Metabolic Responses to Umbilical Cord Occlusions in Fetal Sheep. 
Bull. Math. Biol. 2015, 77, 2264–2293. 
  
16 
Figure legends 
 
Figure 1. Visual abstract. Adverse intrauterine conditions impact the three key components of 
the cardiac pacemaker synchronization (CPS) and its development pre- and postnatally by: 1) 
affecting ion channels function directly, 2) impacting the spatial organization of cardiac pacemaker 
cells, i.e., their channel microdomains and the isolating tissue and 3) reducing energy availability 
in brown adipose tissue, thereby resulting in greater vulnerability to future insults. This conceptual 
understanding lends itself to identification of candidate biomarkers to capture this three-pronged 
approach to fetal programming of the CPS function. 
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